พอดคาสท์ Biotechnology ชั้นนำ (2024)

1
Is Chiral Switching Still Relevant in Today’s Pricing Control Scenario?

1d ago

—

Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy […]Sourceโดย DrugPatentWatch

1
Emerging Tech Trends in Biotechnology with Steven Bressler 39:19

2d ago39:19

39:19

The rapid advancements in biotechnology are transforming the industry. Emerging technologies hold the promise of revolutionizing healthcare and enhancing our quality of life. In this episode, I sit down with Steven Bressler, a fractional CIO from Strategic Technology Management, Inc., to discuss the latest trends in biotechnology. We explore the po…

1
How to Develop a Competitive Edge in Generic Drug Development

2d ago

—

Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate […]Sourceโดย DrugPatentWatch

1
How to Find Key Starting Materials (KSMs) for Pharmaceutical APIs

2d ago

—

To identify Key Starting Materials (KSMs) for Active Pharmaceutical Ingredients (APIs), pharmaceutical companies and regulatory bodies follow a systematic approach […]Sourceโดย DrugPatentWatch

1
How to Navigate the Generic Drug Market Post-COVID

2d ago

—

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the […]Sourceโดย DrugPatentWatch

1
The Regulatory Maze: How Generic Drugs Navigate FDA Approval

3d ago

—

In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […]Sourceโดย DrugPatentWatch

1
Drafting Detailed Drug Patent Claims: The Art and Science of Pharmaceutical IP Protection

3d ago

—

In the high-stakes world of pharmaceutical innovation, drafting detailed drug patent claims is a critical process that can make or […]Sourceโดย DrugPatentWatch

1
Biologic Product Hopping: Innovation or Market Manipulation?

3d ago

—

As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […]Sourceโดย DrugPatentWatch

1
The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity

4d ago

—

Enantiomer Switching: A Pharmaceutical Strategy to Extend Drug Patents Enantiomer switching, also known as chiral switching, is a strategy employed […]Sourceโดย DrugPatentWatch

1
Cracking the Biosimilar Code: A Deep Dive into Effective IP Strategies

5d ago

—

In the rapidly evolving landscape of biosimilars, intellectual property (IP) strategy is paramount. Biosimilar manufacturers face unique challenges, including navigating […]Sourceโดย DrugPatentWatch

1
Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview

6d ago

—

Introduction The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office […]Sourceโดย DrugPatentWatch

1
From Chaos to Clarity: Mastering Your CDMO Transition Like a Pro

9d ago

—

Transitioning to a new Contract Development and Manufacturing Organization (CDMO) can be a complex and challenging process. However, by following […]Sourceโดย DrugPatentWatch

1
Winning Drug Patent Disputes: Proven Strategies for Pharmaceutical Companies

10d ago

—

The High Stakes of Pharmaceutical Patent Litigation In the fiercely competitive pharmaceutical industry, patent disputes can make or break a […]Sourceโดย DrugPatentWatch

1
Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide

11d ago

—

Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […]Sourceโดย DrugPatentWatch

1
The Complexity Advantage: Why Advanced Delivery Methods Deter Generic Competition

12d ago

—

The Strategic Advantage of Complex Drug Delivery Systems In the highly competitive pharmaceutical landscape, adopting complex drug delivery systems can […]Sourceโดย DrugPatentWatch

1
Rx for Change: How Nonprofit Pharma is Reshaping the Industry

12d ago

—

An HHS report titled “The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential […]Sourceโดย DrugPatentWatch

1
CDMO Value Proposition: Why It Matters

16d ago

—

The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the […]Sourceโดย DrugPatentWatch

1
Biosimilar Patent Dance: Leveraging PTAB Challenges for Strategic Advantage

16d ago

—

In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […]Sourceโดย DrugPatentWatch

1
Looking at an Old Paradigm through a Different Lens with Nathan McBride 45:51

16d ago45:51

45:51

As companies evolve, the structuring and management of data become critical for scalability and efficiency. Failure to prioritize this can hinder the adoption of advanced technologies like machine learning. Nathan McBride, Senior Vice President of IT at Xilio Therapeutics, Inc., joins me today to explore the intricacies of effective data structurin…

1
Viagra’s Resilience in the Face of Generic Competition: A Pharmaceutical Market Analysis

17d ago

—

This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]Sourceโดย DrugPatentWatch

1
The impact of biosimilars on biologic drug distribution models

18d ago

—

The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to […]Sourceโดย DrugPatentWatch

1
Unified Patent Court Reshapes European Patent Landscape

18d ago

—

In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent […]Sourceโดย DrugPatentWatch

1
How to find low-competition generic drug opportunities

18d ago

—

To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or […]Sourceโดย DrugPatentWatch

1
Patenting Drugs Developed with Artificial Intelligence: Navigating the Legal Landscape

19d ago

—

The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI’s ability to analyze […]Sourceโดย DrugPatentWatch

1
China Leads in AI-Driven Drug Discovery Patents, Signaling Pharmaceutical Innovation Boom

21d ago

—

China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […]Sourceโดย DrugPatentWatch

1
The Power of Patience: Delaying Patents to Enhance Pharma Market Exclusivity

25d ago

—

The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […]Sourceโดย DrugPatentWatch

1
How can pharmaceutical marketing evolve with generic entry? The example of Lipitor

26d ago

—

Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […]Sourceโดย DrugPatentWatch

1
DrugPatentWatch Week in Review

28d ago

—

Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […]Sourceโดย DrugPatentWatch

1
Best Practices for Drug Patent Portfolio Management

30d ago

—

Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective […]Sourceโดย DrugPatentWatch

1
What is the market forecast for Ozempic?

1M ago

—

This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]Sourceโดย DrugPatentWatch

1
The Double-Edged Sword: Opportunities and Challenges in China’s Patent Litigation System

1M ago

—

Introduction In the rapidly evolving landscape of pharmaceutical patent disputes in China, injunctive relief has emerged as a critical tool […]Sourceโดย DrugPatentWatch

1
Introducing DrugChatter: Revolutionizing Information Access

1M ago

—

DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the […]Sourceโดย DrugPatentWatch

1
USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry

1M ago

—

Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity […]Sourceโดย DrugPatentWatch

1
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents

1M ago

—

The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing […]Sourceโดย DrugPatentWatch

1
The Intricate Journey of Drug Patents: From Filing to Expiry

1M ago

—

In the high-stakes world of pharmaceuticals, patents play a pivotal role in safeguarding intellectual property and ensuring a return on […]Sourceโดย DrugPatentWatch

1
Back to Basics with Pasqual Zottola 40:32

1M ago40:32

40:32

The quality of leadership and innovation in biotechnology is experiencing a significant transformation. Joining me today is Pasqual Zottola, Vice President of Information Technology at Acorda Therapeutics, Inc. We talk about how integrating advanced technological solutions and standout leadership principles leads to sustainable success in biotech. …

1
Uncovering Lucrative Low-Competition Generic Drug Opportunities

1M ago

—

In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area […]Sourceโดย DrugPatentWatch

1
Maximizing ROI with Branded Generics: A Comprehensive Guide

1M ago

—

Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same […]Sourceโดย DrugPatentWatch

1
A Practical Guide to FtO Analysis for Drug Repurposing Ventures

1M ago

—

A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis […]Sourceโดย DrugPatentWatch

1
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

1M ago

—

The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” […]Sourceโดย DrugPatentWatch

1
Innovative Approaches to Extend the Life of Drug Patents

1M ago

—

Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key […]Sourceโดย DrugPatentWatch

1
How long does a patent last for drugs?

1M ago

—

Sure, here’s a more detailed explanation with examples: Drug Patent Duration Drug patents are granted by the United States Patent […]Sourceโดย DrugPatentWatch

1
Crucial Insights on Patent Litigation Strategies in Pharma Industry

2M ago

—

In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. […]Sourceโดย DrugPatentWatch

1
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices

2M ago

—

In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions […]Sourceโดย DrugPatentWatch

1
AI Lending a Hand to Security with Kelly Randis 25:33

2M ago25:33

25:33

We're seeing a revolution in how we protect our data and systems, driven by rapidly evolving threats and the need for more sophisticated defenses. Our guest, Kelly Randis, Head of Global Information Technology at Gamida Cell Ltd., brings over three decades of IT expertise, primarily in the pharmaceutical industry. We discuss how AI is reshaping sec…

1
Garbage In, Garbage Out: Science, Data, Technology with Jonathon Hill 31:02

2M ago31:02

31:02

Science isn't just about discovery; it's about doing it right to ensure reliability and validity. Joining me is Jonathon Hill, an epitome of a scientist, educator, innovator, and the Co-founder and Vice President of Science and Technology at Wasatch Biolabs. Although trained initially as a premed, Jonathon's professional journey took a deep dive in…

1
Data is the key to AI with Keshia Maughn 31:20

3M ago31:20

31:20

The intersection of data and artificial intelligence forms the cornerstone of today's healthcare innovation, transforming the way we approach medical advancements. In this week’s episode, I'm excited to welcome Keshia Maughn from STATinMED, a company carving out its space with a focus on specialized data solutions in biotech. We look at the nuances…

1
Digital Enterprise Capabilities: Beyond IT with Matt Lasmanis 35:17

3M ago35:17

35:17

How do today’s biotech companies cultivate innovation and harness digital tools for strategic growth? In this episode, we dissect the pivotal role that digital enterprise capabilities play in transforming a company's approach to challenges in the life sciences sector. As I chat with Matt Lasmanis, Chief Technology & Innovation Officer at Sage Thera…

1
Innovative Strategies in Drug Repurposing

3M ago

—

Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate […]Sourceโดย DrugPatentWatch

1
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

3M ago

—

The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent […]Sourceโดย DrugPatentWatch

พอดคาสต์ที่ควรค่าแก่การฟัง

Biotechnology พอดคาสต์

พอดคาสต์ที่ควรค่าแก่การฟัง

คู่มืออ้างอิงด่วน